Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Roila

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
Buserelin in the treatment of prostatic cancerF Roila
Oncology|May 1, 1993
Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combinationF Roila
Oncology|June 1, 1996
Control of acute cisplatin-induced emesis over repeat courses of chemotherapy. Italian Group for Antiemetic ResearchF Roila
Tumori|June 9, 1998
[Research on antiemetics: an Italian model of success]F Roila
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2006
New antiemetic drugsF Roila, S Fatigoni
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2002
Quality of life as a primary end point in oncologyF Roila, E Cortesi
Current Opinion in Oncology|August 14, 1998
The efficacy and cost-effectiveness of various antiemetic regimensF Roila, E Ballatori
Current Opinion in Oncology|July 1, 1997
Antiemetics revisitedF Roila, A Del Favero
Clinical Pharmacokinetics|August 1, 1995
Ondansetron clinical pharmacokineticsF Roila, A Del Favero
Tumori|March 20, 1999
[Outcome research: rationales and objectives]A Olivieri, G Recchia, F Roila
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
Buserelin in the treatment of prostatic cancerF Roila
Oncology|May 1, 1993
Ondansetron plus dexamethasone compared to the 'standard' metoclopramide combinationF Roila
Oncology|June 1, 1996
Control of acute cisplatin-induced emesis over repeat courses of chemotherapy. Italian Group for Antiemetic ResearchF Roila
Tumori|June 9, 1998
[Research on antiemetics: an Italian model of success]F Roila
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2006
New antiemetic drugsF Roila, S Fatigoni
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2002
Quality of life as a primary end point in oncologyF Roila, E Cortesi
Current Opinion in Oncology|August 14, 1998
The efficacy and cost-effectiveness of various antiemetic regimensF Roila, E Ballatori
Current Opinion in Oncology|July 1, 1997
Antiemetics revisitedF Roila, A Del Favero
Clinical Pharmacokinetics|August 1, 1995
Ondansetron clinical pharmacokineticsF Roila, A Del Favero
Tumori|March 20, 1999
[Outcome research: rationales and objectives]A Olivieri, G Recchia, F Roila
Pageof 7